Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients

NCT06659458 is registered in ClinicalTrials.gov with Our Lady of the Lake Hospital as lead sponsor.

NCT NCT06659458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06659458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
Lead sponsor
Our Lady of the Lake Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr exon 19 deletion mutation, lung cancer - non small cell